Lorus taps former Wedbush execs for leadership team
Lorus Therapeutics Inc (TSX: LOR) has appointed Avanish Vellanki as chief business officer and Gregory K. Chow as chief financial officer. Previously, Vellanki worked at investment firm Wedbush Securities where he served as senior vice president in investment banking while Chow served as managing director at the same firm. Headquartered in Toronto, Lorus is a biopharmaceutical company. Update: The company has received venture capital investment since the late 1990s.
2 December 2013•4 mins read
